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Abstract
Background: Previous reports on lymphocyte subpop-
ulations  in  systemic  sclerosis  (ssc)  are  conflicting.
therefore,  we  aimed  to  investigate  the  lymphocyte
subsets in ssc patients who were not on immunosup-
pressive therapy. 
Methods: lymphocyte subsets were assessed in the pe-
ripheral blood of ssc patients (n = 29) and healthy
controls (n = 29) using the four colour flow cytometry
method.  Correlation  studies  were  also  performed  in
order to assess the relationship between lymphocyte
subsets and clinical parameters.
Results: the  absolute  count  of  lymphocytes  (P  =
0.0042),  Cd3+  (P  =  0.0014),  Cd4+  (P  =  0.0070),
Cd8+ (P = 0.021), and Cd19+ cells (P = 0.024) was
significantly decreased in ssc patients when compared
to  healthy  controls.  Cd4+/Cd8+  ratio  and  the  ab-
solute count of Cd56+ cells observed in ssc patients
did not significantly differ from controls (P=0.165; P
= 0.632, respectively). there was no substantial rela-
tionship  between  the  lymphocyte  subset  levels  and
clinical features (i.e., ssc subtype, autoantibody pro-
files, organ involvement), except for a significant in-
verse  correlation  of  Cd19+  cells  and  the  modified
Rodnan skin score (r = -0.43, P = 0.020). 
Conclusion: our data support previous reports indicat-
ing that subsets of t lymphocytes as well as B lym-
phocytes play a role in the pathogenesis of ssc.
IntRoduCtIon
systemic sclerosis (ssc) is a connective tissue disease
characterized by excessive extracellular matrix deposi-
tion in the skin and other visceral organs. the most
widely accepted classification system is that proposed
by leRoy et al. [1], which includes limited cutaneous
ssc and diffuse cutaneous ssc, a more rapidly advanc-
ing type with more frequent visceral involvement. It
was suggested that immune system changes play the
major part in the development of vasculopathy and fi-
brosis. the presence of autoantibodies, such as dnA
topoisomerase I and centromere, is a central feature of
ssc. Moreover, a wide range of B and t cell abnor-
malities has been described in ssc. nevertheless, pre-
vious  reports  on  lymphocyte  subpopulations  in  ssc
are conflicting [2-13]. We here conducted a prospec-
tive  study  investigating  lymphocyte  subsets  in  im-
munosuppressant-untreated  ssc  patients  and  healthy
controls.
MAtERIAl And MEtHods
this was a prospective study on patients with ssc who
were evaluated in the department of dermatology of
the Ruhr-university Bochum (Germany) from febru-
ary 2007 to July 2008. ssc was diagnosed according to
the classification system proposed by leRoy et al. [1].
We only included patients who had no history of
photo  pheresis and immunosuppressive treatment (e.g.,
gluco  corticosteroids, methotrexate,cyclophosphamide)
for  at  least  6  months.  the  patients  included  in  the
study, however, had physiotherapy and/or rheological
treatment. We saw to it that the control group, which
included healthy individuals, did match the gender and
age of the patient group. the study was conducted in
the light of the declaration of Helsinki and followed a
protocol approved by our institutional review board.
All  the  patients  and  healthy  controls  were  fully  in-
formed and gave their consent to participate. A com-
plete work-up was performed in ssc patients including
bodyplethysmography,  thoracic  high-resolution  com-
puted  tomography,  oesophagogastroscopy,  abdominal
and cardiac ultrasound, and blood collections. skin in-
volvement was quantified using the modified Rodnan
skin score (MRss) and was assessed clinically by palpa-
tion of the skin, as described previously [14].
In order to identify and determine the percentages
and  absolute  counts  of  lymphocyte  subsets  in  the 
peripheral blood, flow cytometric methods were used.
for  this  purpose  the  following  antibodies  (Bd 
Bio  s  ciences,  san  Jose,  CA,  usA),  directed  against 
mature  human  lymphocyte  subsets  were  employed: 
leucocytes  (Cd45+),  t-lymphocytes  (Cd3+), B-lym-
phocytes  (Cd19+),  helper/inducer  t  lymphocytes
(Cd3+Cd4+),  suppressor/cytotoxic  t  lymphocytes
(Cd3+Cd8+)  and  natural  killer  lymphocytes  (Cd3-
Cd16+ and/or Cd56+). the antibodies were conju-
gated  to  the  following  fluorescent  dyes:  fluorescein
isothiocyanate  (fItC),  phycoerythrin  (PE),  peridinin
chlorophyllprotein  (PerCP)  and allophycocyanine
(APC).  Additionally,  trucount  tubestM (Bd  Biosci  -
ences, san Jose, CA, usA) were used to determine ab-
solute counts of lymphocytes. the fACsCaliburtM
cyto  meter (Bd Biosciences, san Jose, CA, usA),  e  -
quipped with 635 nm and 488 nm lasers, together with
computer  hardware  and  Multitest-softwaretM were
used to acquire and analyse the lymphocyte subsets. 
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package  MedCalc software (Mariakerke, Belgium).
normal  dis  tribution  of  data  was  confirmed  by  the
d’Agostino-Pearson test. data are expressed as mean
ﾱsd and median and range. data were analysed using
the f-test for equal variances, independent t-test, Chi-
square test, and spearman correlation procedure. We
constrained experiment-wise error rates due to multi-
ple  comparisons  to  the  standard  alpha  (P)  level  of
<0.05 by the Bonferroni method.
REsults
All in all, we included 29 patients with ssc. twenty-
two patients had limited ssc, seven patients had dif-
fuse ssc. further clinical data of the patients is de-
tailed in table 1. there was no significant difference
between  ssc  patients  and  healthy  controls  (n  =  29)
with  regard  to  gender  (male/female  ratio:  1/28  vs.
4/25;  P  =  0.29,  respectively)  and  age  (mean  ﾱ  sd:
56.3 ﾱ 12.9 vs. 51.1 ﾱ 13.4; P = 0.13, respectively). As
also detailed in table 2., the absolute count of lym-
phocytes (P = 0.0042), Cd3+ (P = 0.0014), Cd4+ (P
= 0.0070), Cd8+ (P = 0.021), and Cd19+ cells (P =
0.024) was significantly decreased in ssc patients when
compared  to  healthy  controls.  By  contrast,  Cd4+/
Cd8+ ratio and the absolute count of Cd56+ cells
observed  in  ssc  patients  did  not  significantly  differ
from healthy controls (P = 0.165; P = 0.632, respec-
tively). the percentages of lymphocyte subsets investi-
gated did not significantly differ between ssc patients
and  healthy  controls.  there  was  no  substantial  rela-
tionship  between  the  lymphocyte  subset  levels  and
clinical features (i.e., ssc subtype, autoantibody pro-
file,  organ  involvement),  except  for  a  significant  in-
verse correlation of Cd19+ cells and the MRss (r = 
-0.43, P = 0.020).
dIsCussIon
In the present study, we found that ssc patients, who
were not on immunosuppressive treatment, had signif-
icantly reduced numbers of lymphocytes and its sub-
sets including Cd3+, Cd4+, Cd8+, and Cd19 cells.
However, the percentages of lymphocyte subsets in-
vestigated  were  very  similar  to  those  observed  in
healthy  controls.  In  accordance  with  our  results, 
Ercole et al. [7] recently found that ssc patients had
similar percentages of Cd3+, Cd4+, and Cd8+ cells
and  Cd4+/Cd8+  cell  ratio  when  compared  to
matched  normal  controls.  Ingegnoli  et  al.  [8]  found
that absolute counts of Cd4+Cd25+ and Cd8+ lym-
phocytes  are  reduced  in  ssc  patients.  on  the  other
hand, Artlett et al. [9] reported that the numbers of
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Table  1.  Main clinical and laboratory features of
29 patients with systemic sclerosis (ssc).
Gender
(male/female) 1/28
Age
(mean ﾱ sd) 56.3 ﾱ 12.9
SSc type 
(limited/diffuse) 22/7
Duration of disease
(median, months) 42 (1 – 390)
Raynaud phenomenon
(no/yes) 0/29
MRSS
(median) 7 (2 – 24)
Renal involvement
(no/yes) 26/3
Lung involvement
(no/yes) 21/8
Oesophagus involvement
(no/yes) 20/9
Antinuclear antibodies on 
HEp-2 cell line
(negative/anti-centromere/
anti-topoisomerase I) 7/16/6
MRss, modified Rodnan skin score.
Table 2. Peripheral blood lymphocyte subsets in patients with systemic
sclerosis (ssc) and healthy controls.
Lymphocytes  SSc (n = 29) Controls (n = 29) P-value
lymphocytes/ﾵl 1676 ﾱ 602 2273 ﾱ 561 0.0042*
Cd3+
absolute/ﾵl 1193 ﾱ 474 1688 ﾱ 424 0.0014*
percentage (%) 71 ﾱ 7 74 ﾱ 5 0.419
Cd4+
absolute/ﾵl 808 ﾱ 279 1115 ﾱ 346 0.0070*
percentage (%) 49 ﾱ 9 49 ﾱ 8 0.747
Cd4+/Cd8+ ratio 2.3 ﾱ 1.2 2.8 ﾱ 1.6 0.165
Cd8+
absolute/ﾵl 363 ﾱ 256 570 ﾱ 214 0.021*
percentage (%) 21 ﾱ 7 25 ﾱ 8 0.582
Cd19+
absolute/ﾵl 197 ﾱ 89 297 ﾱ 136 0.024*
percentage (%) 12 ﾱ 5 13 ﾱ 4 0.725
Cd56+
absolute/ﾵl 265 ﾱ 153 247 ﾱ 114 0.632
percentage (%) 16 ﾱ 8 11 ﾱ 4 0.0588
*, statistically significant according to independent t-test and Bonferroni-
correction
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Cd4+ and Cd8+ cells were found to be significantly
higher in ssc patients than in controls. However, fioc-
co et al. [6] observed that patients with ssc showed in-
creased  Cd4+Cd26+  and  Cd4+Cd25+  absolute
numbers and percentages and decreased Cd8+Cd29+
percentages compared with controls. 
natural killer cells are large granular lymphocytes
easily  identified  morphologically  by  the  presence  of
azurophil granules in their cytoplasm and they com-
monly  express  certain  cell  surface  markers  such  as
Cd56+ which is a homophilic adhesion molecule that
belongs  to  the  immunoglobulin  superfamily.  natural
killer  cells  mediate  antigen  presentation  and  secrete
immune  modulator  cytokines  like  interferon,  colony
stimulating factor - these functions suggested the in-
volvement of natural killer cells in the pathophysiolo-
gy of ssc. Reduction of natural killer cells has been
described by Riccieri et al. [11]. Interestingly, Mitsuo et
al. [12] observed that the frequency as well as the ab-
solute  number  of  Cd161+Cd8+  cells,  which  are
closely related to Cd8+ natural killer cells, were de-
creased in the peripheral blood of ssc patients.
Presence of autoantibodies and hypergammaglobu-
linaemia  support  the  role  of  humoral  immunity.
Cd19+ is a cell surface marker of B lymphocytes. We
observed significantly reduced levels of Cd19+ cells
which  inversely  correlated  with  the  clinical  score  of
ssc patients. sato et al. [13] found that Cd19 is over-
expressed in naive B cells and, to a greater extent, in
memory B cells in the blood ssc patients. this Cd19
overexpression was specific to ssc, since slE patients
exhibited  significantly  down-regulated  Cd19  expres-
sion. sato et al. [13] suggested that the Cd19 overex-
pression in ssc memory B cells induces both the acti-
vated phenotype of memory B cells and augmented
IgG production. However, Majone et al. [15] recently
reported on increased apoptosis in circulating lympho-
cyte cultures of anti-RnA polymerase III positive pa-
tients with ssc. Indeed, this might be a possible mech-
anism  to  explain  the  reduced  lymphocyte  counts  in
ssc patients.  
In conclusion, the aforementioned data on lympho-
cyte subsets in ssc are conflicting very likely due to
different methodologies particularly with regard to pa-
tient  selection,  pre-treatments,  assays,  and  sample
sizes. Although the relations between the lymphocyte
subpopulations  investigated  was  not  different  from
healthy controls,  we found a significant reduction of
absolute numbers of lymphocytes and Cd3+, Cd4+,
Cd8+,  and  Cd19+  cells  ssc  patients.  Interestingly,
the absolute number of Cd19+ cells appears to in-
versely  correlate  with  the  severity  of  cutaneous  in-
volvement. Hence, the Cd19 count may be a potential
biomarker for the severity of skin involvement. taken
together, our data support previous reports indicating
that subsets of t lymphocytes as well as B lympho-
cytes play a role in the pathogenesis of ssc.
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